Dosing Issues: Target Symptoms and Dose Response
- 1 May 1995
- journal article
- Published by SLACK, Inc. in Psychiatric Annals
- Vol. 25 (5) , 297-300
- https://doi.org/10.3928/0048-5713-19950501-09
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Schizophrenia as a Brain DiseaseArchives of Neurology, 1993
- Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and ClozapineArchives of General Psychiatry, 1992
- Optimal Dose of Neuroleptic in Acute SchizophreniaArchives of General Psychiatry, 1991
- Dosage of Haloperidol for SchizophreniaArchives of General Psychiatry, 1991
- New Antipsychotics: Classification, Efficacy, and Adverse EffectsSchizophrenia Bulletin, 1991
- Neuroleptic Plasma LevelsSchizophrenia Bulletin, 1991
- Fluphenazine Dose, Clinical Response, and Extrapyramidal Symptoms During Acute TreatmentArchives of General Psychiatry, 1990
- A Controlled Dose Comparison of Haloperidol in Newly Admitted Schizophrenic PatientsArchives of General Psychiatry, 1990
- Dose-Related Plasma Levels of ClozapineJournal of Clinical Psychopharmacology, 1989
- Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of PsychosesArchives of General Psychiatry, 1988